Platinum(IV)-Backboned Polymer Prodrug-Functionalized Manganese Oxide Nanoparticles for Enhanced Lung Cancer Chemoimmunotherapy via Amplifying Stimulator of Interferon Genes Activation
- 7 January 2025
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (2) , 2726-2741
Abstract
The stimulator of interferon genes (STING) pathway exhibits great potential in remodeling the immunosuppressive tumor microenvironment and initiating antitumor immunity. However, how to effectively activate STING and avoid undesired toxicity after systemic administration remains challenging. Herein, platinum(IV)-backboned polymer prodrug-coated manganese oxide nanoparticles (DHP/MnO2NP) with pH/redox dual responsive properties are developed to precisely release cisplatin and Mn2+ in the tumor microenvironment and synergistically amplify STING activation. In vitro, we demonstrate that DHP/MnO2NP can effectively induce tumor cell DNA damage and leak into the cytoplasm, cooperating with Mn2+ to promote STING activation and significantly upregulate the expression of proinflammatory cytokines. Additionally, DHP/MnO2NP can selectively release cisplatin and Mn2+ to mediate tumor killing while reducing toxicity to normal cells. In vivo, DHP/MnO2NP exerted increased therapeutic efficacy by inducing STING activation and initiating robust antitumor immunity. Specifically, DHP/MnO2NP effectively skewed tumor-associated macrophages toward a proinflammatory phenotype and upregulated the expression of proinflammatory cytokines in tumors by up to 99-fold relative to the control. And the infiltration of CD8+ T cells was also significantly increased. When STING signaling was blocked, the antitumor effects and immunostimulatory efficacy of DHP/MnO2NP were significantly inhibited. Moreover, DHP/MnO2NP possess the advantage of enhanced tumor homing and retention, resulting in stronger and longer-lasting anticancer effects. Overall, DHP/MnO2NP provide a potential platform for potentiating cancer chemoimmunotherapy and hold promise for precision treatment.Keywords
Funding Information
- West China Hospital, Sichuan University (2024HXBH011, 2024HXBH048)
- National Natural Science Foundation of China (82402351, 92159302)
This publication has 52 references indexed in Scilit:
- Sensitive and Selective Dual‐Mode Responses to Reactive Oxygen Species by Chiral Manganese Dioxide Nanoparticles for Antiaging SkinAdvanced Materials, 2023
- Response and Regulation of the Microenvironment Based on Hollow Structured Drug Delivery SystemsAdvanced Functional Materials, 2023
- Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironmentsAdvanced Drug Delivery Reviews, 2023
- Uncloaking cell-impermeant gold nanorods via tumor microenvironmental cathepsin B facilitates cancer cell penetration and potent radiosensitizationBiomaterials, 2022
- Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapyBiomaterials, 2022
- Dual Size/Charge‐Switchable Nanocatalytic Medicine for Deep Tumor TherapyAdvanced Science, 2021
- Tumor microenvironment triple-responsive nanoparticles enable enhanced tumor penetration and synergetic chemo-photodynamic therapyBiomaterials, 2021
- Albumin‐Templated Manganese Dioxide Nanoparticles for Enhanced Radioisotope TherapySmall, 2017
- Intelligent Albumin–MnO2 Nanoparticles as pH‐/H2O2‐Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination TherapyAdvanced Materials, 2016
- Platinum (IV)-coordinate polymers as intracellular reduction-responsive backbone-type conjugates for cancer drug deliveryBiomaterials, 2011